Open access
Open access
Powered by Google Translator Translator

[Abstract Only] Randomized Trial: Intraperitoneal Cefepime Monotherapy Noninferior to Cefazolin Plus Ceftazidime for Empirical Treatment of Peritoneal Dialysis-associated Peritonitis

18 Aug, 2019 | 21:16h | UTC

Intraperitoneal Cefepime Monotherapy Versus Combination Therapy of Cefazolin Plus Ceftazidime for Empirical Treatment of CAPD-Associated Peritonitis: A Multicenter, Open-Label, Noninferiority, Randomized, Controlled Trial – American Journal of Kidney Diseases (link to abstract – $ for full-text)

 

Related Commentary on Twitter

 


Stay Updated in Your Specialty

 

No spam, just news.